Skip to top bar Skip to header Skip to content Skip to footer

Publications Publication Records - Search Tato aplikace je zatím určena pro spuštění na stolním počítači. Na tomto mobilním zařízení je také funkční, ale zatím plně nevyužívá jeho možností.

Tato aplikace je zatím určena pro spuštění na stolním počítači. Na tomto mobilním zařízení je také funkční, ale zatím plně nevyužívá jeho možností.

Publication Records - Search

Selected publication/outcome records

Urinary intermediates of tryptophan as indicators of the gut microbial metabolism (2017)
Extracellular metabolomics from in vitro fertilization cultivation media (2024)
A review on mass spectrometry-based quantitative proteomics: Targeted and data independent acquisition (2017)
Sulfatide Analysis by Mass Spectrometry for Screening of Metachromatic Leukodystrophy in Dried Blood and Urine Samples (2016)
Fluorimetric assays for N-acetylgalactosamine-6-sulfatase and arylsulfatase B based on the natural substrates for confirmation of mucopolysaccharidoses types IVA and VI (2015)
Tandem Mass Spectrometry Has a Larger Analytical Range than Fluorescence Assays of Lysosomal Enzymes: Application to Newborn Screening and Diagnosis of Mucopolysaccharidoses Types II, IVA, and VI (2015)
Multiplex Assay for Quantification of Acute Phase Proteins and Immunoglobulin A in Dried Blood Spots (2019)
Human White Adipose Tissue Metabolome: Current Perspective (2018)
Lycopene increases metabolic activity of rat liver CYP2B, CYP2D and CYP3A. (2020)
HPLC-MS/MS measurement of lidocaine in rat skin and plasma. Application to study the release from medicated plaster (2020)
Adipophilin and perilipin 3 positively correlate with total lipid content in human breast milk (2020)
Základy vyšetření v klinické imunologii (2020)
Simultaneous quantitative profiling of clinically relevant immune markers in neonatal stool swabs to reveal inflammation (2021)
A comparative study of synthetic winged peptides for absolute protein quantification (2021)
Aspergillus fumigatus tryptophan metabolic route differently affects host immunity (2021)
Patients With Common Variable Immunodeficiency (CVID) Show Higher Gut Bacterial Diversity and Levels of Low-Abundance Genes Than the Healthy Housemates (2021)
Systematic Feature Filtering in Exploratory Metabolomics: Application toward Biomarker Discovery (2021)
Pharyngeal Microbial Signatures Are Predictive of the Risk of Fungal Pneumonia in Hematologic Patients (2021)
Profiling Tryptophan Catabolites of Human Gut Microbiota and Acute-Phase Protein Levels in Neonatal Dried Blood Specimens (2021)
Treatment of cylindrospermopsin by hydroxyl and sulfate radicals: Does degradation equal detoxification (2022)
A High-Risk Profile for Invasive Fungal Infections Is Associated with Altered Nasal Microbiota and Niche Determinants (2022)
Cerebral organoids in disease modeling. (2022)
Single Cerebral Organoid Mass Spectrometry of Cell-Specific Protein and Glycosphingolipid Traits (2023)
Pathogenesis of Alzheimer´s disease: Involvement of the choroid plexus (2023)
Effects of all-trans and 9-cis retinoic acid on differentiating human neural stem cells in vitro (2023)
Replacement Flame-Retardant 2-Ethylhexyldiphenyl Phosphate (EHDPP) Disrupts Hepatic Lipidome: Evidence from Human 3D Hepatospheroid Cell Culture (2023)
Expression of cellular and neurodevelopmental markers in cerebral organoids (2019)
Mass spectrometry-based targeted assay for profiling cell-specific and neurodegeneration protein markers in a single cerebral organoid (2021)
Profiling cell-specific, developmental and neurodegenerative protein markers in cerebral organoids (2021)
Mass Spectrometry-Based Targeted Assay for Profiling Cell-Specific, Developmental and Neurodegeneration Protein Markers in a Single Cerebral Organoid (2021)
Mass Spectrometry Quantitative Proteomics and Exploratory Metabolomics for Biomarker Discovery (2021)
Characterization of Gangliosides in Cerebral Organoids: A New Avenue to Study Aging and Alzheimer’s Disease-Related Cerebral Changes (2021)
Profiling cell-specific, developmental, and neurodegeneration protein markers in a single cerebral organoid (2021)
Single cerebral organoid mass spectrometry analysis: Towards neurodegenerative diseases (2022)
GANGLIOSIDE PROFILING IN CEREBRAL ORGANOIDS: EXPLORING AGING AND ALZHEIMER’S DISEASE RELATED CHANGES (2022)
CEREBRAL ORGANOIDS MODEL SYSTEM FOR NEUROLOGICAL DISEASES (2022)
Characterization of membrane lipids in cerebral organoids (2021)
Advances in mass spectrometry-based metabolomics and quantitative proteomics (2021)
Domino-like effect of C112R mutation on ApoE4 aggregation and its reduction by Alzheimer’s Disease drug candidate (2023)
Cerebral organoids derived from patients with Alzheimer´s disease with PSEN1/2 mutations have defective tissue patterning and altered development (2023)
Application of the mass spectrometry to identify protein markers of Alzheimer's disease (2023)
High-Throughput Microbore LC-MS Lipidomics to Investigate APOE Phenotypes (2024)
Cyanotoxin cylindrospermopsin disrupts lipid homeostasis and metabolism in a 3D in vitro model of the human liver (2024)
Lymphocyte Galactocerebrosidase Activity by LC-MS/MS for Post-Newborn Screening Evaluation of Krabbe Disease (2017)

Remove all the items

Operations on the selected outcomes

Other applications